Literature DB >> 20058203

A three dimensional anchorage independent in vitro system for the prolonged growth of embryoid bodies to study cancer cell behaviour and anticancer agents.

Chui-Yee Fong1, Li-Ling Chak, Arjunan Subramanian, Jee-Hian Tan, Arijit Biswas, Kalamegam Gauthaman, Mahesh Choolani, Woon-Khiong Chan, Ariff Bongso.   

Abstract

We describe a three dimensional (3D) anchorage independent in vitro protocol for the prolonged growth of human embryoid bodies (EBs) up to 90 days. We grew hESCs (46XX) in methylcellulose (MC) in motion culture in the presence of EB medium (EB), EB medium with Matrigel (EB + MAT), bulk culture medium (BCM), and BCM medium with Matrigel (BCM + MAT). All four experimental groups produced embryoid bodies (EBs) which with prolonged growth to 90 days acquired blood vessels and tissues from all three germ layers. Based on histology, microarray gene expression profiles and the definition for experimental teratomas, we could classify the EBs into early EBs, mature EBs and teratomas. The EB + MAT group produced the highest number of teratomas and their microarray data suggested the presence of inductive microenvironment niches and activation of pathways for self-organization, morphogenesis and growth. When we microinjected hepatocarcinoma-Green Fluorescent Protein cells (HepG2-GFP) (46XY) into the teratomas, after 10 days the HepG2-GFP cells had grown inside the teratoma as confirmed by confocal microscopy and SRY gene analysis. This 3D-MC-(EB + MAT) in vitro system requires few cells to produce many teratomas, can be used to test pluripotency of potential human embryonic and induced pluripotent stem cell lines (hESC, hiPSC), and is an experimental humanized platform to study cancer cell behavior.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20058203     DOI: 10.1007/s12015-009-9092-y

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  28 in total

Review 1.  Matrigel: basement membrane matrix with biological activity.

Authors:  Hynda K Kleinman; George R Martin
Journal:  Semin Cancer Biol       Date:  2005-10       Impact factor: 15.707

2.  Complex extracellular matrices promote tissue-specific stem cell differentiation.

Authors:  Deborah Philp; Silvia S Chen; Wendy Fitzgerald; Jan Orenstein; Leonid Margolis; Hynda K Kleinman
Journal:  Stem Cells       Date:  2005-02       Impact factor: 6.277

3.  The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts.

Authors:  Maty Tzukerman; Tzur Rosenberg; Irena Reiter; Shoshana Ben-Eliezer; Galit Denkberg; Raymond Coleman; Yoram Reiter; Karl Skorecki
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

4.  Human embryonic stem cells are prone to generate primitive, undifferentiated tumors in engrafted human fetal tissues in severe combined immunodeficient mice.

Authors:  Chu-Chih Shih; Stephen J Forman; Peiguo Chu; Marilyn Slovak
Journal:  Stem Cells Dev       Date:  2007-12       Impact factor: 3.272

5.  An experimental platform for studying growth and invasiveness of tumor cells within teratomas derived from human embryonic stem cells.

Authors:  Maty Tzukerman; Tzur Rosenberg; Yael Ravel; Irena Reiter; Raymond Coleman; Karl Skorecki
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-22       Impact factor: 11.205

Review 6.  Is teratoma formation in stem cell research a characterization tool or a window to developmental biology?

Authors:  Masa Aleckovic; Carlos Simón
Journal:  Reprod Biomed Online       Date:  2008-08       Impact factor: 3.828

7.  Teratoma formation assays with human embryonic stem cells: a rationale for one type of human-animal chimera.

Authors:  M William Lensch; Thorsten M Schlaeger; Leonard I Zon; George Q Daley
Journal:  Cell Stem Cell       Date:  2007-08-23       Impact factor: 24.633

8.  The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells.

Authors:  Barak Blum; Ori Bar-Nur; Tamar Golan-Lev; Nissim Benvenisty
Journal:  Nat Biotechnol       Date:  2009-03-01       Impact factor: 54.908

9.  Wnt signaling mediates self-organization and axis formation in embryoid bodies.

Authors:  Derk ten Berge; Wouter Koole; Christophe Fuerer; Matt Fish; Elif Eroglu; Roel Nusse
Journal:  Cell Stem Cell       Date:  2008-11-06       Impact factor: 24.633

10.  TiGER: a database for tissue-specific gene expression and regulation.

Authors:  Xiong Liu; Xueping Yu; Donald J Zack; Heng Zhu; Jiang Qian
Journal:  BMC Bioinformatics       Date:  2008-06-09       Impact factor: 3.169

View more
  6 in total

Review 1.  Basement membrane matrix (BME) has multiple uses with stem cells.

Authors:  Irina Arnaoutova; Jay George; Hynda K Kleinman; Gabriel Benton
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

2.  Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells.

Authors:  Chui-Yee Fong; Li-Ling Chak; Arijit Biswas; Jee-Hian Tan; Kalamegam Gauthaman; Woon-Khiong Chan; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

3.  Large particle multiphoton flow cytometry to purify intact embryoid bodies exhibiting enhanced potential for cardiomyocyte differentiation.

Authors:  D G Buschke; A Vivekanandan; J M Squirrell; C T Rueden; K W Eliceiri; B M Ogle
Journal:  Integr Biol (Camb)       Date:  2013-06-13       Impact factor: 2.192

4.  Analysis of embryoid bodies derived from human induced pluripotent stem cells as a means to assess pluripotency.

Authors:  Steven D Sheridan; Vasudha Surampudi; Raj R Rao
Journal:  Stem Cells Int       Date:  2012-03-01       Impact factor: 5.443

Review 5.  Perinatal sources of mesenchymal stem cells: Wharton's jelly, amnion and chorion.

Authors:  Malgorzata Witkowska-Zimny; Edyta Wrobel
Journal:  Cell Mol Biol Lett       Date:  2011-07-18       Impact factor: 5.787

6.  Initiate Tumors with Single Cell Spheres Formed in Serum-Containing Medium.

Authors:  Guozhou Zhang; Kun Xiong; Weiwei Ma; Wei Xu; Huihui Zeng
Journal:  J Cancer       Date:  2015-07-28       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.